Fidelity Investments’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.1M | Sell |
15,627,822
-4,132
| -0% | -$9.55K | ﹤0.01% | 1500 |
|
|
2025
Q1 | $21.7M | Sell |
15,631,954
-733,710
| -4% | -$1.02M | ﹤0.01% | 1646 |
|
|
2024
Q4 | $28.3M | Sell |
16,365,664
-2,312,863
| -12% | -$4M | ﹤0.01% | 1608 |
|
|
2024
Q3 | $37.5M | Sell |
18,678,527
-2,532,109
| -12% | -$5.09M | ﹤0.01% | 1490 |
|
|
2024
Q2 | $47.5M | Buy |
21,210,636
+1,099,919
| +5% | +$2.46M | ﹤0.01% | 1328 |
|
|
2024
Q1 | $57.7M | Sell |
20,110,717
-2,328,407
| -10% | -$6.68M | ﹤0.01% | 1274 |
|
|
2023
Q4 | $39.7M | Sell |
22,439,124
-2,088,677
| -9% | -$3.7M | ﹤0.01% | 1381 |
|
|
2023
Q3 | $77.5M | Buy |
24,527,801
+23,378,974
| +2,035% | +$73.9M | 0.01% | 1084 |
|
|
2023
Q2 | $759K | Sell |
1,148,827
-1,938,511
| -63% | -$1.28M | ﹤0.01% | 2544 |
|
|
2023
Q1 | $2.46M | Sell |
3,087,338
-117,584
| -4% | -$93.8K | ﹤0.01% | 2320 |
|
|
2022
Q4 | $7.24M | Sell |
3,204,922
-80,861
| -2% | -$183K | ﹤0.01% | 2014 |
|
|
2022
Q3 | $6.34M | Sell |
3,285,783
-9,906
| -0.3% | -$19.1K | ﹤0.01% | 2086 |
|
|
2022
Q2 | $12.3M | Buy |
3,295,689
+868
| +0% | +$3.23K | ﹤0.01% | 1861 |
|
|
2022
Q1 | $21.5M | Sell |
3,294,821
-985,673
| -23% | -$6.43M | ﹤0.01% | 1754 |
|
|
2021
Q4 | $49.9M | Sell |
4,280,494
-1,478,180
| -26% | -$17.2M | ﹤0.01% | 1422 |
|
|
2021
Q3 | $107M | Buy |
5,758,674
+71,058
| +1% | +$1.32M | 0.01% | 1075 |
|
|
2021
Q2 | $121M | Buy |
5,687,616
+23,401
| +0.4% | +$496K | 0.01% | 1041 |
|
|
2021
Q1 | $115M | Hold |
5,664,215
| – | – | 0.01% | 1008 |
|
|
2020
Q4 | $148M | Buy |
5,664,215
+1,456,641
| +35% | +$38M | 0.01% | 869 |
|
|
2020
Q3 | $90.1M | Buy |
+4,207,574
| New | +$90.1M | 0.01% | 957 |
|